BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27705841)

  • 1. Human dihydrofolate reductase influences the sensitivity of the malaria parasite Plasmodium falciparum to ketotifen - A cautionary tale in screening transgenic parasites.
    Tran PN; Tate CJ; Ridgway MC; Saliba KJ; Kirk K; Maier AG
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):179-183. PubMed ID: 27705841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puromycin-N-acetyltransferase as a selectable marker for use in Plasmodium falciparum.
    de Koning-Ward TF; Waters AP; Crabb BS
    Mol Biochem Parasitol; 2001 Oct; 117(2):155-60. PubMed ID: 11606225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
    de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
    Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
    Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
    Zhang K; Rathod PK
    Science; 2002 Apr; 296(5567):545-7. PubMed ID: 11964483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro potentiation of chloroquine activity in Plasmodium falciparum by ketotifen and cyproheptadine].
    Quan H; Tang LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):338-42. PubMed ID: 19157295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New selectable markers and single crossover integration for the highly versatile Plasmodium knowlesi transfection system.
    Wel Av; Kocken CH; Pronk TC; Franke-Fayard B; Thomas AW
    Mol Biochem Parasitol; 2004 Mar; 134(1):97-104. PubMed ID: 14747147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy.
    Milner E; Sousa J; Pybus B; Auschwitz J; Caridha D; Gardner S; Grauer K; Harris E; Hickman M; Kozar MP; Lee P; Leed S; Li Q; Melendez V; Moon J; Ngundam F; O'Neil M; Parriott S; Potter B; Sciotti R; Tangteung A; Dow GS
    Eur J Drug Metab Pharmacokinet; 2012 Mar; 37(1):17-22. PubMed ID: 22314893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
    Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
    Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.
    Sandefur CI; Wooden JM; Quaye IK; Sirawaraporn W; Sibley CH
    Mol Biochem Parasitol; 2007 Jul; 154(1):1-5. PubMed ID: 17451822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
    Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
    Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of split-dihydrofolate reductase for the detection of protein-protein interactions and simultaneous selection of multiple plasmids in Plasmodium falciparum.
    Levray YS; Berhe AD; Osborne AR
    Mol Biochem Parasitol; 2020 Jul; 238():111292. PubMed ID: 32505674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Plasmodium falciparum, Nima-related kinase Pfnek-4: a marker for asexual parasites committed to sexual differentiation.
    Reininger L; Garcia M; Tomlins A; Müller S; Doerig C
    Malar J; 2012 Jul; 11():250. PubMed ID: 22849771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker.
    Sultan AA; Thathy V; de Koning-Ward TF; Nussenzweig V
    Mol Biochem Parasitol; 2001 Mar; 113(1):151-6. PubMed ID: 11254963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.
    Heinberg A; Kirkman L
    Ann N Y Acad Sci; 2015 Apr; 1342(1):10-8. PubMed ID: 25694157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determination of antifolate resistance associated point mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthetase (dhps) genes among the field samples in Arunachal Pradesh.
    Sharma J; Khan SA; Dutta P; Mahanta J
    J Vector Borne Dis; 2015 Jun; 52(2):116-21. PubMed ID: 26119542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
    Fernandes N; Figueiredo P; do Rosário VE; Cravo P
    Malar J; 2007 Mar; 6():35. PubMed ID: 17378942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine resistance.
    Tahar R; Basco LK
    Am J Trop Med Hyg; 2007 Aug; 77(2):221-7. PubMed ID: 17690390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.